Corticosteroids were first prescribed in the 1940s for patients with RA when Dr. Phillip Hench introduced cortisone to the world.
It was immediately hailed as a “miracle drug” and the cure for RA. High-dose cortisone was so potent and dramatically effective in the
treatment of RA that Hench and his colleague Kendall received the Nobel Prize in 1950 for their work.
It soon became apparent, however, that this powerful medication caused some serious side effects, particularly at the very high doses
being prescribed at that time. Because of this, most physicians in the 1960s and 1970s tried to avoid prescribing any corticosteroids.
Corticosteroids continue to produce side effects, but physicians have become more cautious in prescribing the medication. Physicians
generally follow these guidelines for use of corticosteroids. They are to be used
•      by people whose arthritis cannot be controlled adequately by non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying
anti-rheumatic drugs (DMARDs) or by people who cannot take NSAIDs or DMARDs because of unacceptable side effects;
•      in the smallest dose possible which allows the person to function (the medication should be taken in the morning as a single dose);
and
•       for the shortest time possible.
If the dose and duration of corticosteroid use can be limited, the number of side effects can be diminished significantly. Treatment of some
of the rare and severe complications of RA does involve taking larger doses of corticosteroids.
It is common practice for doctors to prescribe low-dose corticosteroids on a temporary basis. If NSAIDs prove ineffective
(or cause intolerable side effects), corticosteroids can be substituted temporarily to control inflammation rapidly while awaiting
the effects of the slower-acting DMARDs. This is called bridge therapy. After the inflammation is controlled, corticosteroids need
to be tapered off slowly under a physician’s guidance. One should never abruptly discontinue corticosteroids without the supervision of a doctor.

A note of caution is in order here: do not let the relief provided by corticosteroids lull you into a false sense of security which causes
you to think about trying to avoid treatment with second-line drugs. Corticosteroids are extremely potent anti-inflammatory drugs, but they
may not halt the disease process.
*104/209/5*
ARTHRITIS

Before starting methotrexate therapy discuss the following with your physician:
•     A history of liver problems (especially hepatitis), stomach ulcer, alcohol use, kidney or lung problems, blood problems, human immunodeficiency virus (HIV) infection, or a positive tuberculin skin test or tuberculosis.
•      Any medications you are currently taking, but particularly sulfa drugs, other antibiotics (particularly those containing trimethaprim), NSAIDs, diuretics (water pills), probenecid (gout medication), and medications to treat seizures or diabetes.

While taking methotrexate:
•       Contact your physician promptly if you notice mouth sores, nausea or vomiting, black or tar-colored stools, fever or chills, sore throat, unusual bleeding or bruising, a change in skin or urine color, cough or shortness of breath, or a marked increase in fatigue.
•      Inform your physician, surgeon, or dentist that you are taking methotrexate well before he or she performs any medical procedure.
•      Never take this medication more than one day a week.
•      Alcohol ingestion is prohibited.
•      Take every precaution to avoid pregnancy.
•      Frequent liver function tests and blood tests to obtain complete blood counts are required. Blood tests for kidney function and urine studies may be requested periodically by your physician.

Pregnancy and breastfeeding
Methotrexate is an extremely dangerous medication for the fetus. It has been known to cause fetal death and birth defects. Women should avoid getting pregnant for at least one full menstrual cycle after stopping methotrexate. Men should wait at least three months after discontinuing methotrexate treatment before trying to father children. Do not breastfeed while taking methotrexate.
*98/209/5*
ARTHRITIS

Like the other immunosuppressants, methotrexate can produce side effects. The most commonly reported problems involve stomach intolerance and mouth sores. Nausea, vomiting, and diarrhea can usually be minimized by dividing up the weekly dose; that is, the standard prescription for methotrexate calls for taking the complete weekly dose all at one time, once a week. Anyone who experiences stomach problems from methotrexate can take one pill every several hours on that one day of the week (if your dose is three pills per week, for example, you would take one pill every eight hours on the day of your treatment). You cannot divide the dose up throughout the week, however. Your doctor will help you with a schedule that is tolerable for you. Other possibilities include taking the medication with food, adjusting the dose, and taking anti-nausea medications. Some people tolerate an intramuscular shot of methotrexate better than the pill form.
The most frequent side effect that causes concern involves the liver. In people taking methotrexate, blood tests that measure liver enzymes are frequently elevated slightly, but this is rarely an indication of a serious liver problem. With long-term use, however, inflammation and scarring of the liver can take place. Although cirrhosis of the liver is a distinctly rare side effect, some people with psoriatic arthritis have developed cirrhosis of the liver from methotrexate. Scarring and cirrhosis appear to be much less common in RA patients. The risk of liver problems can be minimized greatly if the person avoids alcohol and keeps his or her weight down. After several years of methotrexate use, a liver biopsy may be indicated, particularly if liver blood test abnormalities persist.
Blood counts (white and red blood cells and platelets) can be lowered by methotrexate use. At the dose used to treat RA, this side effect is unusual. When it occurs, it is almost always reversible by discontinuing the use or reducing the dose of the drug. Reduced platelet counts increase bleeding risks in some people. When the white blood cell count is markedly lowered, serious infections can occur; much more rarely, unusual or atypical infections develop while white blood counts are at normal levels. These infections can develop because of methotrexate’s effect on the immune system.
Another serious side effect is lung inflammation or pneumonitis. This inflammation is generally reversible with discontinuation of methotrexate and treatment with corticosteroids. Pneumonitis can, on rare occasions, be life threatening.
Recent studies that suggest that taking folic acid (or folate) supplements decreases the side effects of methotrexate.
*97/209/5*
ARTHRITIS

Azulfidine
Generic available: yes
Tablet size: 500 mg
Enteric-coated tablets: 500 mg
Liquid form is available.
Usual dose: two or three pills twice daily
Effective within: two to six months
Sulfasalazine, a medication commonly prescribed to treat colitis, was developed by Professor Nanna Svartz in Stockholm and was originally designed in the 1930s for the treatment of RA. Sulfa drugs were just being developed at that time, when RA was considered to be an infectious condition. Sulfasalazine contained both an antibiotic (sulfa) and an anti-inflammatory (salicylate) component. It was used throughout the 1940s with proven effectiveness but eventually fell into disfavor for political reasons and because the new miracle drug, cortisone, became available.
There has been a resurgence of interest in sulfasalazine in the past decade after several new studies proved its effectiveness. Despite these findings, use of this drug for RA has not yet been approved by the Federal Drug Administration (FDA). Nevertheless, rheumatologists (including the authors) frequently prescribe sulfasalazine for RA because of its effectiveness and low incidence of serious side effects.
Side effects of sulfasalazine. Individuals taking this medication complain more frequently of stomach problems than of any other side effects. Although sulfasalazine is most effective when taken on an empty stomach, taking it with meals is acceptable and helps prevent stomach discomfort. Enteric-coated tablets (available at a higher price than un-coated tablets) also help in this regard. Beginning treatment with low doses and increasing the dose slowly also improve stomach acceptance.
Decreased sperm counts and changes in the sperm can occur, temporarily decreasing fertility. Sperm counts return to normal approximately two months after sulfasalazine use has been discontinued.
Serious side effects are rare and usually appear early in the course of treatment. Most worrisome are severe sulfa allergic reactions, hepatitis, and a decrease in the number of white blood cells, red blood cells, and platelets. The majority of people recover from these side effects when the medication is discontinued and proper treatment is given.
Before starting sulfasalazine therapy discuss the following with your physician:
•      Allergy to sulfa or antibiotics.
•      A history of kidney or liver problems.
•      Any medications you are taking to treat diabetes, blood pressure, seizures, or heart ailments or to thin the blood.
While taking sulfasalazine:
•     Avoid or protect yourself against sun exposure.
•      Inform your physician immediately if you develop a rash, blood in your urine, fever, bruising or easy bleeding, sore throat, cough, or shortness of breath.
•       Your physician will intermittently order complete blood counts, liver function tests, and urine tests to monitor and control the side effects.
Pregnancy and breastfeeding. Avoid use of this medication during pregnancy. Although birth defects have not been reported, caution suggests the use of birth control methods until sulfasalazine has been discontinued for two months.
*95/209/5*
ARTHRITIS

© 2011 Arthritis Suffusion theme by Sayontan Sinha